Pfizer has appointed former Patrizia Cavazzoni, MD, former director of the FDA’s Center for Drug Evaluation and Research, as its new chief medical officer, Bloomberg reported Feb. 24.
Dr. Cavazzoni, who left the FDA in January, will oversee regulatory, safety and medical operations at Pfizer.
She had led the FDA’s drug division, which oversees new therapy approvals, since 2020. Dr. Cavazzoni’s appointment also marks a return to Pfizer, where she had held senior vice president roles for about eight years, according to her LinkedIn page.
The U.S. is facing its second-largest measles outbreak in 25 years, with 884 confirmed cases reported, according to the latest…
Taylor Hospital in Ridley Park, Pa., closed April 26 after a bankruptcy court approved Prospect Medical Holdings’ plan to wind…
Oakland, Calif.-based Kaiser Permanente faces $819,500 in fines after state officials said the organization delayed handling complaints from health plan…
Comments are closed.
